Anti-inflammation strategy may be good for myocardial prognosis, but some anti-inflammatory cytokines such as IL-10 and TGF-β reduced in acute coronary syndrome (ACS) patients, reflecting the imbalance in systemic cytokine response following an ACS [22–24]. This evidence concerns the gene TGFB1 and acute coronary syndrome.